Company: SNSE
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064525
Chunk: 1

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Item 1
Chunk 1
---
, 2025 and December 31, 2024; 25,208,068 and 25,180,583 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively

     3

     3

     Additional paid-in capital

     300,906

     300,448

     Accumulated deficit

     (268,916
     )

     (262,052
     )

     Accumulated other comprehensive loss

     (6
     )

     (13
     )

     Total stockholders’ equity

     31,987

     38,386

     Total liabilities and stockholders’ equity
      
     $
     38,273

     $
     45,361

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.